AMPAR inhibition lowers S1P in human blood and improves murine autoimmune neuroinflammation by blocking T cell egress from lymph nodes
Science Translational Medicine · 2025
DOI: 10.1126/scitranslmed.ads6434 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, 2025. Verfasst von Beatrice Wasser und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Research Center for Immunotherapy (FZI) and Focus Program Translational Neuroscience (FTN), Rhine-Main Neuroscience Network …. Hauptthemen laut MEDLINE: Lymph Nodes, T-Lymphocytes, Receptors, AMPA, Sphingosine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 75 Literaturangaben.
Abstract (Originalsprache)
Glutamatergic α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR)–mediated signaling in neurons acts through regulation of ion channels. In T cells, we uncovered a noncanonical AMPAR-mediated metabotropic G i protein–coupled signaling pathway. Selective blockade of AMPAR ameliorated disease severity in experimental autoimmune encephalomyelitis (EAE) both in SJL mice, which typically show a relapsing-remitting disease course, and in C57BL/6 mice, representing chronic disease activity. AMPAR blockade led to a retention of T cells in lymph nodes resulting in reduced T cell numbers within the central nervous system. RNA sequencing and functional analysis of the lymphocyte AMPAR pathway revealed that the AMPAR antagonist perampanel inhibited G i protein–coupled signaling and induced migration-modifying transcription programs, including CD69. CD69 + T cells showed down-regulated expression of sphingosine 1-phosphate (S1P) receptor, a key regulator of T cell egress. Reduced T cell egress from lymph nodes upon AMPAR blockade was rescued by anti-CD69 antibody treatment or addition of S1P. Perampanel treatment additionally reduced S1P blood concentrations in mice and patients with epilepsy. Combined AMPAR and S1P receptor inhibition had an additive beneficial effect on disease severity in C57BL/6 EAE, and single AMPAR treatment was sufficient to almost completely abolish disease development in SJL EAE. Our findings suggest that AMPAR blockade can counteract neuroinflammation caused by the infiltration of T cells into the central nervous system in conditions such as multiple sclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Research Center for Immunotherapy (FZI) and Focus Program Translational Neuroscience (FTN), Rhine-Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University…
- Institute of Pathophysiology, FTN, University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany.
- Institute of Molecular Medicine III, University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, 40225 Düsseldorf, Germany.
- Department of Neurology, University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, 40225 Düsseldorf, Germany.
- Institute of Anatomy, Medical Faculty Carl Gustav Carus, Technische Universität Dresden School of Medicine, 01307 Dresden, Germany.
- Mainz Epilepsy and Sleep Medicine Center, Department of Neurology, University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany.
ORCID-Profile: Beatrice Wasser, Manuela Ecker, Nicholas Hanuscheck, Kira Engeroff, Benedikt Grünewald, Philipp Wollnitzke, Christina B Schroeter, Mirko H H Schmidt, Muthuraman Muthuraman, Bodo Levkau, Yaroslav Winter, Sven G Meuth, Robert Nitsch, Stefan Bittner, Frauke Zipp
Zitieren
APA
Wasser, B., Ecker, M., Hanuscheck, N., Ellwardt, E., Gärtner, Y., Engeroff, K., Domingues, M., Grünewald, B., Oshaghi, M., Wollnitzke, P., Schroeter, C. B., Schmidt, M. H. H., Muthuraman, M., Levkau, B., Winter, Y., Meuth, S. G., Nitsch, R., von Engelhardt, J., Bittner, S., & Zipp, F. (2025). AMPAR inhibition lowers S1P in human blood and improves murine autoimmune neuroinflammation by blocking T cell egress from lymph nodes. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.ads6434
Vancouver
Wasser B, Ecker M, Hanuscheck N, Ellwardt E, Gärtner Y, Engeroff K, et al. AMPAR inhibition lowers S1P in human blood and improves murine autoimmune neuroinflammation by blocking T cell egress from lymph nodes. Science Translational Medicine. 2025. doi:10.1126/scitranslmed.ads6434
BibTeX
@article{Wasser2025,
author = {Wasser, Beatrice and Ecker, Manuela and Hanuscheck, Nicholas and Ellwardt, Erik and Gärtner, Yvonne and Engeroff, Kira and Domingues, Micaela and Grünewald, Benedikt and Oshaghi, Mohammadsaleh and Wollnitzke, Philipp and Schroeter, Christina B and Schmidt, Mirko H H and Muthuraman, Muthuraman and Levkau, Bodo and Winter, Yaroslav and Meuth, Sven G and Nitsch, Robert and von Engelhardt, Jakob and Bittner, Stefan and Zipp, Frauke},
title = {AMPAR inhibition lowers S1P in human blood and improves murine autoimmune neuroinflammation by blocking T cell egress from lymph nodes},
journal = {Science Translational Medicine},
year = {2025},
doi = {10.1126/scitranslmed.ads6434}
}
EUVIMED